Related Experiment Video
Updated: Aug 16, 2026

Establishing the Minimal Bactericidal Concentration of an Antimicrobial Agent for Planktonic Cells (MBC-P) and Biofilm Cells (MBC-B)
Published on: January 2, 2014
Minocycline in the chemoprophylaxis of meningococcal disease
Abstract:
An outbreak of meningococcal disease occurred among basic combat trainees at Fort Lewis, Wash., in the first 3 months of 1971. After five recruits developed meningitis within a 2-week period, 8,721 recruits were given 100 mg of minocycline every 12 hr for 5 days. No new cases of meningococcal disease occurred for almost 5 weeks. Then six additional cases occurred among recruits who had entered training after the initial course of minocycline and who had not received the drug. Minocycline was given to all 6,130 of these men, and again occurrence of new cases was halted abruptly. One week later, group C polysaccharide vaccine was administered to all recruits in the first 6 weeks of training and subsequently to all new entering trainees. No new cases of meningitis occurred in the next 3 months. Surveys showed that minocycline significantly lowered the meningococcal carrier rate for 4 to 5 weeks. No strains of Neisseria meningitidis, among 341 isolated after minocycline treatment, were resistant to the drug. Prophylaxis with minocycline clearly interrupted the course of this outbreak due to sulfa-resistant meningococci. Although immunization is the preferred method of prophylaxis, minocycline may be useful until a suitable polyvalent vaccine is available.
Insights
Minocycline effectively halted an outbreak of meningococcal disease in military recruits by reducing carriers. While vaccines are preferred, minocycline offers a valuable alternative for meningococcal disease prophylaxis.
Area of Science:
- Epidemiology
- Infectious Diseases
- Microbiology
Background:
- A meningococcal disease outbreak occurred among basic combat trainees at Fort Lewis, Washington, in early 1971.
- The outbreak involved sulfa-resistant strains of Neisseria meningitidis.
Purpose of the Study:
- To evaluate the efficacy of minocycline in controlling an outbreak of meningococcal disease.
- To assess the impact of minocycline on meningococcal carrier rates.
Main Methods:
- Administered 100 mg of minocycline every 12 hours for 5 days to 8,721 recruits.
- Administered minocycline to an additional 6,130 recruits who entered training later.
- Administered group C polysaccharide vaccine to recruits in the first 6 weeks of training.
Main Results:
- Minocycline administration halted new cases of meningococcal disease.
- No new cases occurred for nearly 5 weeks after the initial minocycline course.
- Minocycline significantly lowered the meningococcal carrier rate for 4 to 5 weeks.
- No resistant strains of Neisseria meningitidis were isolated after minocycline treatment.
Conclusions:
- Minocycline prophylaxis was effective in interrupting the meningococcal disease outbreak.
- Minocycline reduced meningococcal carrier rates, indicating its potential as a prophylactic agent.
- While immunization is preferred, minocycline may serve as a useful alternative until a suitable polyvalent vaccine is available.
Related Concept Videos
Microbial Corrosion
Rocky Mountain Spotted Fever
Mechanism of Antibiotic Resistance in MRSA
Cryptococcal Meningitis
Inhibitors of Bacterial Protein Synthesis
Clinical Significance of Antibiotic Resistance

